Background
Transcatheter Aortic Valve Implantation (TAVI) is increasingly used to treat patients with severe aortic stenosis at high surgical risk. The severity of post-implantation valvular or paravalvular regurgitation has been shown to adversely affect patient outcome. The aim of the study was to assess the prevalence and severity of aortic regurgitation (AR) at 6 months post-TAVI using cardiovascular magnetic resonance (CMR).
Methods
Twenty five severe aortic stenosis patients underwent a 1.5T CMR (Intera, Philips Healthcare) scan at baseline and 6 months after CoreValve™ TAVI. LV function was assessed using cine imaging with a steady state free precession pulse sequence. The LV outflow tract was imaged in two planes and through-plane phase contrast velocity imaging was performed perpendicular to the aortic valve and transverse to the aorta at the sinotubular junction. Postprocessing was performed using QMass 7.2 and QFlow 5.2 (Medis, Netherlands). AR severity was defined using regurgitant fraction (RF) as: none to mild <8%, mild to moderate 8 to 19%, moderate to severe 20 to 29% and severe >30% [1] .
Transthoracic echocardiography (iE33, Philips Healthcare) was performed at baseline and 6 months follow-up. Aortic regurgitation was graded using a comprehensive integrated approach following the recent Valve Academic Research Consortium (VARC) guidelines.
Results
Mean age was 80.6±6.6yrs, 44% were female, Logistic EuroSCORE 19.5±14.9 LV ejection fraction significantly improved post-TAVI (52.1±11.8% vs. 55.9±9.6%, p<0.0001) and reduction in indexed end-systolic LV volume (46±18 ml/m 2 vs. 41±17 ml/m 2 , p = 0.02). The end-diastolic volume (95±18 ml/m 2 vs. 91±20 ml/m 2 , p = ns) and stroke volume (48±10 ml/m 2 vs. 50±10 ml/m 2 , p = ns) did not change.
There was a significant reduction in aortic RF 6 months post-TAVI (median RF 12.4%, IQR 5.6 to 16.8% vs. 6.2% IQR 3.6 to 13.2%,p=0.034 ) ( Figure 1 ). There was no significant difference between the transthoracic echo grading and CMR grading of aortic regurgitation. (Chi-squared = 3.74 p = 0.159) ( Figure 2) .
Echocardiography showed there was also a statistically significant reductions in peak forward flow velocity (4.87 ±0.57 ms -1 vs.1.98±0.35 ms -1 p < 0.05), peak pressure gradient (96.1±24.3 mmHg vs.17±5.7 mmHg p < 0.05) and mean pressure gradient (54.8±15.9 mmHg vs.8±3 mmHg p < 0.05) compared to baseline; the effective orifice area (EOA) was significantly larger compared to the baseline state (0.57±0.03 cm 2 vs. 1.63±0. 3cm 2 p < 0.05).
Conclusions
There was an overall reduction in aortic regurgitant fraction post-TAVI even in the presence of pre-existing AR. CMR can be used in the TAVI population, pre-and postprocedure to quantify the degree of aortic regurgitation 
